Novel approaches are encouraged by the wide range of chronic conditions, such as diabetes, autoimmune diseases, and pain management. With their longer wear periods and intuitive features, on-body injectors strike the ideal balance between the patient’s desire for more control over their health and the convenience and consistency of drug delivery. The emphasis on patient autonomy and self-management in healthcare is growing. This trend is nicely complemented by on-body injectors, which give patients more comfort and autonomy over their therapy. Patients looking for discreet and practical drug delivery options are driving market demand as a result of this shift in focus. The early emphasis on insulin delivery in the therapy of diabetes is quickly giving way to a more diverse range of uses. Recent research is looking on using on-body injectors to deliver painkillers, antibiotics, and vaccines.
Needle stick injuries (NSIs) have the potential to provide a serious obstacle to the market expansion for wearable injectors. Healthcare personnel are at significant risk of contracting bloodborne infections such as HIV, hepatitis B, and hepatitis C from these unintentional needle pricks or punctures caused by tainted needles. Hospitals and physicians are forced to bear the financial burden of costly post-exposure prophylaxis (PEP) treatments, medical monitoring, and potential lawsuits as a result of NSIs. The emotional weight of worry, dread, and possible stigmatization that NSIs place on healthcare personnel can have an adverse effect on their well-being and level of job satisfaction. Wearable injectors may come under fire due to unfavorable media coverage or high-profile NSI incidents, which could raise questions about their safety and discourage patients and healthcare professionals from using them.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Wearable Injectors Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Wearable Injectors Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
Wearable Injectors Market based on Type:
- On-Body Injectors
- Off-Body Injectors
Wearable Injectors Market based on Therapy:
- Oncology
- Autoimmune Disease
- Diabetes
- Cardiovascular Disease
- Others
Wearable Injectors Market based on End-user:
- Hospitals and Clinics
- Home Care
- Others
Wearable Injectors Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The market for wearable injectors is divided into segments according to kind, usage, technology, injection mechanism, therapeutic area, end user, and geography. The market is segmented into three types: hand held, off body (belt held), and on body (adhesive patch). It is divided into semi-reusable and disposable categories based on usage. It is divided into electrical, mechanical, and other types of injectors based on technology. It can be classified as motor driven, spring driven, expanding battery, rotary pump, collapsible reservoir, or pressurized gas depending on the injection mechanism. Diabetes, cancer, cardiovascular disease, infectious diseases, and auto immune disorders are the therapeutic areas that make up this division. It is separated into ambulatory surgery facilities, clinics, hospitals, home care settings, and other categories based on the end user.
The market is split into on-body and off-body segments based on kind. The on-body injectors segment held a dominant position in the market in 2020, and this trend is anticipated to persist throughout the forecast period due to their easy application technique and lack of equipment requirements.
It is divided into semi-reusable and disposable categories based on usage. Due to its low creation of medical waste and reusability, the semi-reusable sector held a dominant position in the market in 2020.
It is divided into electronic injectors, mechanical injectors, and other categories based on technology. Due to its lower device size and cost-effectiveness, the mechanical injectors category led the market in 2020 and is predicted to maintain this position throughout the forecast period.
It is classified as motor driven, spring driven, expanding battery, rotary pump, collapsible reservoir, and pressurized gas based on the injection mechanism. Due to its easier-to-use and more reliable equipment, the spring-driven segment dominated the market in 2020 and is predicted to maintain this trend throughout the forecast period.
It is separated into diabetes, cancer, cardiovascular disease, infectious disease, and auto immune disorder categories based on the therapeutic areas. Because diabetes is so common throughout the world, the diabetes sector dominated the market in 2020.
It is separated into clinics, hospitals, ambulatory surgery centers, home care settings, and other categories based on the end user. In 2020, the market was dominated by the home care settings segment, and this trend is anticipated to continue during the forecast period, owing to convenience of use for geriatric population.
Due to the high rates of diabetes, cancer, and cardiovascular disease, the expansion of hospitals and diagnostic facilities, and the growing popularity of home-based therapies, Asia-Pacific offers significant prospects for major players in the wearable injectors market. The need for patient-centered therapy and the approval of the use of different biologics in the treatment of diseases also support the market’s expansion. The wearable injectors market in the Asia-Pacific region is also anticipated to rise because to the increased attention of major manufacturers on geographical expansion in order to gain a larger part of the industry.
Enable Injections, United Therapeutics (Steadymed Therapeutics, Inc.), Insulet Corporation, Medtronic PLC, Sensile Medical Ag, West Pharmaceutical Services, and other important players are among those highlighted in this research.
- This report illustrates the most vital attributes of the Wearable Injectors Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Wearable Injectors Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Wearable Injectors Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Wearable Injectors Market.
List of Tables
TABLE 1. WEARABLE INJECTORS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 2. WEARABLE INJECTORS MARKET VALUE FOR ON-BODY INJECTORS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. WEARABLE INJECTORS MARKET VALUE FOR OFF-BODY INJECTORS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. WEARABLE INJECTORS MARKET VALUE, BY THERAPY, 2021-2030 (USD BILLION)
TABLE 5. WEARABLE INJECTORS MARKET VALUE FOR ONCOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. WEARABLE INJECTORS MARKET VALUE FOR AUTOIMMUNE DISEASE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. WEARABLE INJECTORS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. WEARABLE INJECTORS MARKET VALUE FOR CARDIOVASCULAR DISEASE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 10. WEARABLE INJECTORS MARKET VALUE FOR HOSPITALS AND CLINICS, 2021-2030 (USD BILLION)
TABLE 11. WEARABLE INJECTORS MARKET VALUE FOR HOME CARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. WEARABLE INJECTORS MARKET VALUE FOR OTHERS, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA WEARABLE INJECTORS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 15. NORTH AMERICA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 17. U.S WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 18. U.S WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 19. U.S WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 20. CANADA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 21. CANADA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 22. CANADA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 23. MEXICO WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 24. MEXICO WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 25. MEXICO WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 26. EUROPE WEARABLE INJECTORS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 27. EUROPE WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 28. EUROPE WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 29. EUROPE WEARABLE INJECTORS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION)
TABLE 30. GERMANY WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 31. GERMANY WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 32. GERMANY WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 33. U.K WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 34. U.K WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 35. U.K WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 36. FRANCE WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 37. FRANCE WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 38. FRANCE WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 39. ITALY WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 40. ITALY WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 41. ITALY WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 42. SPAIN WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 43. SPAIN WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 44. SPAIN WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 45. ROE WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 46. ROE WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 47. ROE WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC WEARABLE INJECTORS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 50. ASIA PACIFIC WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 51. ASIA PACIFIC WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 52. CHINA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 53. CHINA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 54. CHINA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 55. INDIA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 56. INDIA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 57. INDIA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 58. JAPAN WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 59. JAPAN WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 60. JAPAN WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 62. REST OF APAC WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 63. REST OF APAC WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 65. LATIN AMERICA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 66. LATIN AMERICA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 68. BRAZIL WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 69. BRAZIL WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 71. ARGENTINA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 72. ARGENTINA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 74. MIDDLE EAST AND AFRICA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 75. MIDDLE EAST AND AFRICA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 77. SAUDI ARABIA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 78. SAUDI ARABIA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 79. UAE WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 80. UAE WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 81. UAE WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA WEARABLE INJECTORS MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 83. REST OF MIDDLE EAST AND AFRICA WEARABLE INJECTORS MARKET VALUE, BY INDICATION, 2021-2030 (USD BILLION)
TABLE 84. REST OF MIDDLE EAST AND AFRICA WEARABLE INJECTORS MARKET VALUE, BY END-USER, 2021-2030 (USD BILLION)
TABLE 85. AMGEN INC.: FINANCIALS
TABLE 86. AMGEN INC.: PRODUCTS & SERVICES
TABLE 87. AMGEN INC.: RECENT DEVELOPMENTS
TABLE 88. BECTON, DICKINSON AND COMPANY: FINANCIALS
TABLE 89. BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES
TABLE 90. BECTON, DICKINSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 91. DEXCOM, INC.: FINANCIALS
TABLE 92. DEXCOM, INC.: PRODUCTS & SERVICES
TABLE 93. DEXCOM, INC.: RECENT DEVELOPMENTS
TABLE 94. ENABLE INJECTIONS: FINANCIALS
TABLE 95. ENABLE INJECTIONS: PRODUCTS & SERVICES
TABLE 96. ENABLE INJECTIONS: RECENT DEVELOPMENTS
TABLE 97. INSULET CORPORATION: FINANCIALS
TABLE 98. INSULET CORPORATION: PRODUCTS & SERVICES
TABLE 99. INSULET CORPORATION: RECENT DEVELOPMENTS
TABLE 100. SENSILE MEDICAL: FINANCIALS
TABLE 101. SENSILE MEDICAL: PRODUCTS & SERVICES
TABLE 102. SENSILE MEDICAL: RECENT DEVELOPMENTS
TABLE 103. TANDEM DIABETES CARE, INC.: FINANCIALS
TABLE 104. TANDEM DIABETES CARE, INC.: PRODUCTS & SERVICES
TABLE 105. TANDEM DIABETES CARE, INC.: DEVELOPMENTS
TABLE 106. YPSOMED: FINANCIALS
TABLE 107. YPSOMED: PRODUCTS & SERVICES
TABLE 108. YPSOMED: RECENT DEVELOPMENTS
TABLE 109. BUHLER MOTOR GMBH: FINANCIALS
TABLE 110. BUHLER MOTOR GMBH: PRODUCTS & SERVICES
TABLE 111. BUHLER MOTOR GMBH: RECENT DEVELOPMENTS
TABLE 112. WEST PHARMACEUTICAL SERVICES, INC.: FINANCIALS
TABLE 113. WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS & SERVICES
TABLE 114. WEST PHARMACEUTICAL SERVICES, INC.: RECENT DEVELOPMENTS
